Dr. Galina Vugman, MD
What this data tells you about Dr. Vugman
Dr. Galina Vugman is a hematology & oncology specialist in Sarasota, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Vugman performed 85,852 Medicare services across 3,108 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vugman received a total of $2,521 from 29 pharmaceutical and/or device companies across 74 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vugman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Florida License Status
FL DOH · MQA| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 103860 | Clear | January 31, 2027 | — |
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 52,530 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 11,800 | $42 | $123 |
| Denosumab injection (Prolia/Xgeva) | 5,100 | $18 | $48 |
| Paclitaxel chemotherapy injection | 4,809 | $0 | $1 |
| Dexamethasone injection (steroid) | 2,140 | $0 | $1 |
| Epoetin alfa injection (Retacrit) for anemia | 1,520 | $6 | $21 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,451 | $1 | $31 |
| Office visit, established patient (30-39 min) | 853 | $92 | $202 |
| Office visit, established patient (20-29 min) | 606 | $61 | $135 |
| Anti-nausea injection (ondansetron/Zofran) | 488 | $0 | $1 |
| Injection, carboplatin, 50 mg | 393 | $2 | $8 |
| Administration of chemotherapy into vein, 1 hour or less | 369 | $98 | $327 |
| Complete blood count (CBC) with differential | 294 | $8 | $22 |
| Blood draw (venipuncture) | 287 | $8 | $14 |
| Comprehensive metabolic blood panel | 281 | $10 | $30 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 266 | $22 | $74 |
| Drug injection, under skin or into muscle | 224 | $10 | $50 |
| Office visit, established patient, complex (40-54 min) | 216 | $133 | $279 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 169 | $48 | $154 |
| Hospital follow-up visit, moderate complexity | 155 | $64 | $138 |
| Administration of additional new drug or substance into vein, 1 hour or less | 137 | $50 | $152 |
| New patient office visit, complex (60-74 min) | 118 | $165 | $412 |
| Injection, zoledronic acid, 1 mg | 114 | $7 | $59 |
| New patient office visit (45-59 min) | 106 | $124 | $328 |
| Irrigation of implanted venous access drug delivery device | 101 | $14 | $60 |
| Collection of blood sample from implanted device | 87 | $15 | $50 |
| Administration of chemotherapy into vein, each additional hour | 87 | $22 | $69 |
| Ferritin level test (iron stores) | 83 | $13 | $39 |
| Iron level test | 83 | $6 | $18 |
| Iron binding capacity test | 79 | $9 | $24 |
| Initial hospital admission, high complexity | 75 | $137 | $386 |
| Injection, diphenhydramine hcl, up to 50 mg | 70 | $1 | $3 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 69 | $49 | $172 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 57 | $138 | $545 |
| Infusion, normal saline solution , 1000 cc | 56 | $2 | $6 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 55 | $23 | $80 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 54 | $1 | $6 |
| Injection of additional new drug or substance into vein | 48 | $12 | $49 |
| Administration of additional new drug or substance into vein using push technique | 44 | $43 | $147 |
| Hospital follow-up visit, high complexity | 42 | $93 | $198 |
| Infusion into a vein for hydration, 31-60 minutes | 39 | $24 | $125 |
| Infusion into a vein for hydration, each additional hour | 37 | $10 | $33 |
| Vitamin B-12 level test | 32 | $15 | $43 |
| Red blood count automated, with additional calculations | 32 | $5 | $11 |
| Hospital follow-up visit, low complexity | 30 | $40 | $76 |
| Thyroid stimulating hormone (TSH) test | 29 | $16 | $48 |
| Folic acid level test | 25 | $14 | $42 |
| Free thyroxine (T4) test | 21 | $9 | $25 |
| Complete blood count (CBC), automated | 19 | $6 | $18 |
| Microscopic examination for white blood cells with manual cell count | 18 | $4 | $10 |
| Sed rate test (inflammation marker) | 16 | $3 | $8 |
| Testosterone (hormone) level, total | 14 | $25 | $71 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $15 | $40 |
| Office visit, established patient (10-19 min) | 12 | $34 | $81 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Vugman is a mixed practice specialist, with above-average Medicare volume (top 9% in FL), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Vugman experienced with iron infusion (feraheme)?
Does Dr. Vugman receive payments from pharmaceutical companies?
How do Dr. Vugman's costs compare to other hematology & oncology specialists in Sarasota?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology